EP3600319A4 - Neuartige alpha-hydroxy-carbonsäure und derivate und andere gras-basierte prodrugs von opioiden und verwendungen davon - Google Patents

Neuartige alpha-hydroxy-carbonsäure und derivate und andere gras-basierte prodrugs von opioiden und verwendungen davon Download PDF

Info

Publication number
EP3600319A4
EP3600319A4 EP18774382.8A EP18774382A EP3600319A4 EP 3600319 A4 EP3600319 A4 EP 3600319A4 EP 18774382 A EP18774382 A EP 18774382A EP 3600319 A4 EP3600319 A4 EP 3600319A4
Authority
EP
European Patent Office
Prior art keywords
gras
opioids
derivatives
carboxylic acid
hydroxy carboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18774382.8A
Other languages
English (en)
French (fr)
Other versions
EP3600319A1 (de
Inventor
John K. Thottathil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/472,758 external-priority patent/US10449190B2/en
Application filed by Individual filed Critical Individual
Publication of EP3600319A1 publication Critical patent/EP3600319A1/de
Publication of EP3600319A4 publication Critical patent/EP3600319A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Addiction (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP18774382.8A 2017-03-29 2018-03-27 Neuartige alpha-hydroxy-carbonsäure und derivate und andere gras-basierte prodrugs von opioiden und verwendungen davon Withdrawn EP3600319A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/472,758 US10449190B2 (en) 2015-04-27 2017-03-29 Alpha-hydroxy carboxylic acid and derivatives and other GRAS-based prodrugs of opioids and uses thereof
PCT/US2018/024476 WO2018183264A1 (en) 2017-03-29 2018-03-27 Novel alpha-hydroxy carboxylic acid and derivatives and other gras- based prodrugs of opioids and uses thereof

Publications (2)

Publication Number Publication Date
EP3600319A1 EP3600319A1 (de) 2020-02-05
EP3600319A4 true EP3600319A4 (de) 2020-11-25

Family

ID=63676908

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18774382.8A Withdrawn EP3600319A4 (de) 2017-03-29 2018-03-27 Neuartige alpha-hydroxy-carbonsäure und derivate und andere gras-basierte prodrugs von opioiden und verwendungen davon

Country Status (2)

Country Link
EP (1) EP3600319A4 (de)
WO (1) WO2018183264A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2969330A1 (en) * 2014-12-01 2016-06-09 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
US10226456B2 (en) 2015-04-27 2019-03-12 3St Research Llc Methods and compositions for preventing opioid abuse
WO2022038365A2 (en) 2020-08-21 2022-02-24 Sitryx Therapeutics Limited Novel compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011002995A1 (en) * 2009-07-02 2011-01-06 Kempharm, Inc. Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, methods of making and use thereof
US20160326182A1 (en) * 2015-04-27 2016-11-10 Waterville Valley Technologies, Inc. Methods and compositions for preventing opioid abuse

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040058946A1 (en) * 2002-07-05 2004-03-25 Buchwald Stephen L. Abuse-resistant prodrugs of oxycodone and other pharmaceuticals
CN1263760C (zh) * 2002-11-12 2006-07-12 财团法人奇美医院 新颖的丁丙诺啡酯衍生物及其制备方法，以及长效作用镇痛药学组合物
WO2009130270A1 (en) * 2008-04-24 2009-10-29 Janssen Pharmaceutica Nv Nalmefene di-ester prodrugs
JP2013523599A (ja) * 2009-04-02 2013-06-17 シャイア エルエルシー 新規なオピオイドのジカルボン酸結合アミノ酸及びペプチドプロドラッグ並びにその用途
US10449190B2 (en) * 2015-04-27 2019-10-22 John K. Thottathil Alpha-hydroxy carboxylic acid and derivatives and other GRAS-based prodrugs of opioids and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011002995A1 (en) * 2009-07-02 2011-01-06 Kempharm, Inc. Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, methods of making and use thereof
US20160326182A1 (en) * 2015-04-27 2016-11-10 Waterville Valley Technologies, Inc. Methods and compositions for preventing opioid abuse

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO2018183264A1 *
SZABOLCS BÉNI ET AL: "Preparation of benzoate esters of morphine and its derivatives", MONATSHEFTE FÜR CHEMIE - CHEMICAL MONTHLY ; AN INTERNATIONAL JOURNAL OF CHEMISTRY, SPRINGER-VERLAG, AU, vol. 143, no. 10, 26 June 2012 (2012-06-26), pages 1431 - 1440, XP035116687, ISSN: 1434-4475, DOI: 10.1007/S00706-012-0803-8 *

Also Published As

Publication number Publication date
WO2018183264A1 (en) 2018-10-04
EP3600319A1 (de) 2020-02-05

Similar Documents

Publication Publication Date Title
EP3541932A4 (de) Inhibitoren von crispr-cas9
EP3380098A4 (de) Neuartige alpha-hydroxycarbonsäure und derivate und andere gras-basierte prodrugs von oxycodon und verwendungen davon
EP3681854A4 (de) Formung von terephthalsäureestern
EP3288958A4 (de) Zusammensetzungen aus obeticholsäure und verfahren zur verwendung
EP3234027A4 (de) Wässrige beschichtungszusammensetzung und verfahren zur herstellung davon
EP3292116B8 (de) 3-aryl-4-amido-bicyclische [4,5,0]hydroxamsäuren als hdac-hemmer
EP3331530A4 (de) Mthfd2-inhibitoren und verwendungen davon
EP3473614A4 (de) Sulfonsäureesterverbindung und verwendung davon
EP3558303A4 (de) Aminosäureverbindungen und verfahren zur verwendung
EP3555076A4 (de) Neuartige phenylpropionsäurederivate und verwendungen davon
EP3145505A4 (de) Inhibitoren der amidase von n-acylethanolamin-hydrolysierender säure (naaa) und verwendung davon
EP3563853A4 (de) Zusammensetzung von mannurondicarbonsäure
EP3529232A4 (de) Sulfaminsäurederivate und herstellungsverfahren dafür
EP3532633A4 (de) Zusammensetzungen und verfahren zur herstellung von verbindungen
EP3094718A4 (de) Mikroorganismen für die erhöhte produktion von aminosäuren und zugehörige verfahren
EP3473613A4 (de) Sulfonsäureesterverbindung und verwendung davon
EP3615515A4 (de) Propionsäurederivate und verfahren zur verwendung davon
EP3713920A4 (de) Oxoacridinylessigsäurederivate und verfahren zur verwendung
EP3211040A4 (de) Modifiziertes polyasparaginsäureester und härtbare harzzusammensetzung
EP3660023A4 (de) Verbindung als acc-inhibitor und deren verwendung
EP3234046A4 (de) Wässrige beschichtungszusammensetzung und verfahren zur herstellung davon
EP3458448A4 (de) Verfahren zur verwendung von fasn-hemmern
EP3655409A4 (de) Neue verbindungen und ihre verwendung als acc-inhibitoren
EP3149099A4 (de) Synthetische säurezusammensetzungen und verwendungen davon
EP3109230A4 (de) Klasse von carbonsäurederivaten und verwendung davon bei der herstellung von prodrugs

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190924

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 489/04 20060101ALI20200710BHEP

Ipc: A61P 25/36 20060101ALI20200710BHEP

Ipc: C07D 489/08 20060101ALI20200710BHEP

Ipc: A61K 31/485 20060101ALI20200710BHEP

Ipc: C07D 489/02 20060101AFI20200710BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20201027

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 489/04 20060101ALI20201021BHEP

Ipc: C07D 489/02 20060101AFI20201021BHEP

Ipc: A61P 25/36 20060101ALI20201021BHEP

Ipc: C07D 489/08 20060101ALI20201021BHEP

Ipc: A61K 31/485 20060101ALI20201021BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210526